Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Urol ; 30(12): 1122-1132, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37602677

ABSTRACT

OBJECTIVES: This study aims to reveal immunophenotypes associated with immunotherapy response in bladder cancer, identify the signature genes of immune subtypes, and provide new molecular targets for improving immunotherapy response. METHODS: Bladder cancer immunophenotypes were characterized in the bulk RNA sequencing dataset GSE32894 and Imvigor210, and gene expression signatures were established to identify the immunophenotypes. Expression of gene signatures were validated in single-cell RNA sequencing dataset GSE145140 and human proteins expression data source. Investigation of Immunotherapy Response was performed in IMvigor210 dataset. Prognosis of tumor immunophenotypes was further analyzed. RESULTS: Inflamed and immune-excluded immunophenotypes were characterized based on the tumor immune cell scores. Risk score models that were established rely on RNA sequencing profiles and overall survival of bladder cancer cohorts. The inflamed tumors had lower risk scores, and the low-risk tumors were more likely to respond to atezolizumab, receiving complete response/partial response (CR/PR). Patients who responded to atezolizumab had higher SRRM4 and lower NPHS1 and TMEM72 expression than the non-responders. SRRM4 expression was a protective factor for bladder cancer prognosis, while the NPHS1 and TMEM72 showed the opposite pattern. CONCLUSION: This study provided a novel classification method for tumor immunophenotypes. Bladder cancer immunophenotypes can predict the response to immune checkpoint blockade. The immunophenotypes can be identified by the expression of signature genes.


Subject(s)
Nephrotic Syndrome , Urinary Bladder Neoplasms , Humans , Urinary Bladder Neoplasms/drug therapy , Urinary Bladder Neoplasms/genetics , Urinary Bladder , Immunotherapy , Tumor Microenvironment , Prognosis , Nerve Tissue Proteins
2.
ISA Trans ; 98: 1-10, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31558286

ABSTRACT

This paper proposes a constraint-tolerant design with sliding mode strategy to improve the stability of aircraft engine control. To handle the difficulties associated with the high-frequency switching laws, merely attenuating the chattering is far from satisfactory. System constraints on input, output, and input rate should be addressed in the design process. For a sort of uncertain nonlinear systems subjected to the constraints, sliding mode regulators are designed using Lyapunov analysis. A turbofan engine is adopted for simulation, which shows that the methodology developed in this paper can handle the speed tracking and limit protection problem in a stable fashion, despite the negative influence posed by the system constraints.

SELECTION OF CITATIONS
SEARCH DETAIL
...